Abstract:Objective To study the clinical manifestations and gene mutations of Chinese long QT syndrome (LQTS) patients.MethodsAccording to the criteria by Schwartz 1993, probands of 85 families from 18 provinces were diagnosed as LQTS. Among them the information about 43 patients was provided by the National Registry, and a definite diagnosis for others were confirmed in our center. Six or 12 lead ECG for the probands and their family members was recorded and clinical manifestations for all probands were analyzed. Gene mutations were screened in KCNQ1,KCNH2 and KCNE1 using PCR and sequence analysis. ResultsThe age distribution for the first attack of probands is 17.3±14.2, and 60% of patients had their first attack before the age of 20. The sex distribution (male∶female) is around 1∶3, and the most prominent symptom is syncope (91.8%). The triggers are emotional stress (51.3%), physical stress, exercise or overwork (51.3%), during sleep or rest (26.3%), sudden noise/arousal (19.7%), menses or puerperium(15.8%), others (cold or fever) (15.8%). The QTc for probands is (0.56±0.07)s. The T wave morphology is varied, and QT interval could become temporarily normal. The families with sudden death history make up 31.6% of total 85 families. The families with more than 2 LQTS patients make up 63%. Among 85 probands, 1 case accompanied by deaf-mute, 1 case by WPW, 2 cases by myocarditis, 2 cases by bundle branch block, 1 by temporary atrio-ventricular block and 2 by hypertention. The predictive genotypic results by ECG characteristics are LQT1 (29.4%), LQT2(57.6%), LQT3(3.5%), and unpredictable (9.4%). The pacemaker plus β-blocker are effective for 4 patients and ICD plus β-blocker are effective for 1 patient. Left cardiac sympathetic denervation (LCSD) was performed on 15 patients. The therapy with β-blockers was conducted on most of other patients. Seven KCNQ1, 5 KCNH2 and 1 KCNE1 mutations have been identified in Chinese LQTS patients. Coexpression of HERG-R863X with wild-type HERG showed reduced current densities through no trafficing to the cell surface. KCNQ1-L191P and KCNE1-G52R have a dominant negative effect on I Ks, which reduces the I Ks current amplitude. ConclusionThe general clinical manifestations for Chinese LQTS patients are consistent with that reported by investigators from other countries. The predictive genotype results by ECG characteristics suggested that the major genotype for Chinese LQTS patients might be LQT2.β-blockers are the first-line therapy for LQTS patients. LCSD, pacemaker and ICD implantation are the choices for β-blocker resistant patients. Genetic and electrophysiological tests have shown promising results, suggesting that Chinese LQTS patients may have their own specific mutation sites and pathophysiological mechanisms.

Bioinformatic Analysis of Key Genes in Cardiotoxic Compound Induced Long QT Interval

Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome

Lqts Gene Lovd Database

Risk for Life-Threatening Cardiac Events in Patients with Genotype-Confirmed Long-Qt Syndrome and Normal-Range Corrected QT Intervals.

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Mutations In Cytoplasmic Loops Of The Kcnq1 Channel And The Risk Of Life-Threatening Events Implications For Mutation-Specific Response To Beta-Blocker Therapy In Type 1 Long-Qt Syndrome

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

GW24-e3969 the Common Genotypes of Long QT Syndrome and the Role of ECG Prediction the China Experience

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study

Prognostic Implications of Mutation-Specific QTc Standard Deviation in Congenital Long QT Syndrome.

Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel

Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.

Long QT Syndrome Diagnosed by Genetic Analysis in Six Pedigress

Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways

Whole-exome sequencing and electrophysiological study reveal a novel loss-of-function mutation of KCNA10 in epinephrine provoked long QT syndrome with familial history of sudden cardiac death

Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome

Latent Genetic Backgrounds and Molecular Pathogenesis in Acquired Long Qt Syndrome with Distinct Arrhythmic Triggers

Clinical Characteristics of 85 Probands with Long QT Syndrome and an Update of Genetic Study in China

Identification of critical genes and molecular pathways in COVID-19 myocarditis and constructing gene regulatory networks by bioinformatic analysis

PM024 the Common Genotypes of Long Qt Syndrome and the Role of Electrocardiogram Prediction---The China Experience